Miho Suzuki
- Molecular Biology
- Epidemiology top 10%
- Immunology top 10%
- Endocrinology, Diabetes and Metabolism top 5%
- Oncology top 10%
- Co-authors
- Masahiko MiharaMisato HashizumeMasashi ShiinaHiroto YoshidaKikuo KasaiYoshiyuki HattoriSachiko HattoriYow‐Wu B. Wu
- Topics
- Thyroid Disorders and Treatments (9 papers)Head and Neck Cancer Studies (7 papers)Thyroid Cancer Diagnosis and Treatment (7 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEThe Journal of Clinical Endocrinology & Metabolism
- Partner nations
- JapanUnited StatesIreland
In The Last Decade
Miho Suzuki
80 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Molecular Biology 427
- Epidemiology 395
- Immunology 364
- Endocrinology, Diabetes and Metabolism 359
- Oncology 332
Countries citing papers authored by Miho Suzuki
This map shows the geographic impact of Miho Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miho Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miho Suzuki more than expected).
Fields of papers citing papers by Miho Suzuki
This network shows the impact of papers produced by Miho Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miho Suzuki. The network helps show where Miho Suzuki may publish in the future.
Co-authorship network of co-authors of Miho Suzuki
This figure shows the co-authorship network connecting the top 25 collaborators of Miho Suzuki. A scholar is included among the top collaborators of Miho Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miho Suzuki. Miho Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | Obesity does not diminish the efficacy of IL-6 signalling blockade in mice with collagen-induced arthritis. | 4 |
| 3 | 1 | |
| 4 | Accelerated idioventricular rhythm induced by a high concentration of sevoflurane : Two case reports | 0 |
| 5 | 13 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 74 | |
| 9 | 2 | |
| 10 | 1 | |
| 11 | Clinico-pathological study about prognostic factors on 56 cases of adenoid cystic carcinoma | 1 |
| 12 | 16 | |
| 13 | 31 | |
| 14 | 0 | |
| 15 | 207 | |
| 16 | Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis | 1 |
| 17 | 38 | |
| 18 | Operative treatment of femoral neck fracture : mainly arthroplasty | 0 |
| 19 | Single-dose intravenous toxicity study of DWA2114R in mice, rats and dogs | 1 |
| 20 | One year oral toxicity study of levonorgestrel in female cynomolgus monkeys | 1 |
About Miho Suzuki
Miho Suzuki is a scholar working on Otorhinolaryngology, Endocrinology, Diabetes and Metabolism and Speech and Hearing, having authored 93 papers that have together received 2.5k indexed citations. Recurring topics across this work include Thyroid Disorders and Treatments (9 papers), Head and Neck Cancer Studies (7 papers) and Thyroid Cancer Diagnosis and Treatment (7 papers). The work is most often cited by research in Research and Theory (81 citations), Leadership and Management (30 citations) and Endocrinology, Diabetes and Metabolism (359 citations). Miho Suzuki has collaborated with scholars based in Japan, United States and Ireland. Frequent co-authors include Masahiko Mihara, Misato Hashizume, Masashi Shiina, Hiroto Yoshida, Kikuo Kasai, Yoshiyuki Hattori, Sachiko Hattori, Hiroto Yoshida, Yow‐Wu B. Wu and Carol S. Brewer. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.